packageNavitoclax

navitoclax

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Navitoclax is an investigational anticancer drug being studied as a treatment for cancer. It is not approved for general use and remains under clinical investigation.

Summary written by glm-5.3-flash from Wikidata Q18002993 and the WHO ATC classification; not checked by a person.

name:navitoclax
ATC codes:L01XX78
DrugBank:DB12340
PubChem CID:24978538
ChEBI:131174
Wikidata:Q18002993
formula:C47H55ClF3N5O6S3
molar mass:974.61 g/mol (PubChem CID 24978538)
logP:9.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown